A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521
Clinical trial NCT05323045 · COMPLETED
Trial details
- NCT number
- NCT05323045
- Sponsor
- Byondis B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-21
- Primary completion
- 2024-03-04
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.